Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Flaherty

Showing results (91-100 of 242) with videos related to

Pageof 25
Sort By:
The American Journal of Emergency Medicine|June 28, 2021
Ventricular tachycardia after naloxone administration in an adolescentCatherine E Naber, Nonyerem O Acholonu, Neil D Fernandes, et al.
BMJ Open Respiratory Research|July 5, 2022
Study design and rationale for the TETON phase 3, randomised, controlled clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosisSteven D Nathan, Jurgen Behr, Vincent Cottin, et al.
American Journal of Respiratory and Critical Care Medicine|June 23, 2016
Effect of Nintedanib in Subgroups of Idiopathic Pulmonary Fibrosis by Diagnostic CriteriaGanesh Raghu, Athol U Wells, Andrew G Nicholson, et al.
Plos One|August 5, 2016
Six-SOMAmer Index Relating to Immune, Protease and Angiogenic Functions Predicts Progression in IPFShanna L Ashley, Meng Xia, Susan Murray, et al.
The European Respiratory Journal|March 3, 2007
Idiopathic pulmonary fibrosis fibroblasts migrate and proliferate to CC chemokine ligand 21E M Pierce, K Carpenter, C Jakubzick, et al.
The European Respiratory Journal|January 24, 2015
Oral immunotherapy with type V collagen in idiopathic pulmonary fibrosisDavid S Wilkes, Terrence Chew, Kevin R Flaherty, et al.
The European Respiratory Journal|December 22, 2023
Effects of nintedanib on symptoms in patients with progressive pulmonary fibrosisMarlies Wijsenbeek, Jeffrey J Swigris, Yoshikazu Inoue, et al.
The Lancet. Respiratory Medicine|December 10, 2016
The diagnosis of idiopathic pulmonary fibrosis: current and future approachesFernando J Martinez, Alison Chisholm, Harold R Collard, et al.
Arthritis and Rheumatism|August 6, 2005
Comparison of disease progression and mortality of connective tissue disease-related interstitial lung disease and idiopathic interstitial pneumoniaS V Kocheril, B E Appleton, E C Somers, et al.
Respiratory Medicine|February 3, 2016
Hypersensitivity pneumonitis and antigen identification--An alternate approachM L Millerick-May, M H Mulks, J Gerlach, et al.
Pageof 25

Showing results (91-100 of 242) with videos related to

Sort By:
Pageof 25
The American Journal of Emergency Medicine|June 28, 2021
Ventricular tachycardia after naloxone administration in an adolescentCatherine E Naber, Nonyerem O Acholonu, Neil D Fernandes, et al.
BMJ Open Respiratory Research|July 5, 2022
Study design and rationale for the TETON phase 3, randomised, controlled clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosisSteven D Nathan, Jurgen Behr, Vincent Cottin, et al.
American Journal of Respiratory and Critical Care Medicine|June 23, 2016
Effect of Nintedanib in Subgroups of Idiopathic Pulmonary Fibrosis by Diagnostic CriteriaGanesh Raghu, Athol U Wells, Andrew G Nicholson, et al.
Plos One|August 5, 2016
Six-SOMAmer Index Relating to Immune, Protease and Angiogenic Functions Predicts Progression in IPFShanna L Ashley, Meng Xia, Susan Murray, et al.
The European Respiratory Journal|March 3, 2007
Idiopathic pulmonary fibrosis fibroblasts migrate and proliferate to CC chemokine ligand 21E M Pierce, K Carpenter, C Jakubzick, et al.
The European Respiratory Journal|January 24, 2015
Oral immunotherapy with type V collagen in idiopathic pulmonary fibrosisDavid S Wilkes, Terrence Chew, Kevin R Flaherty, et al.
The European Respiratory Journal|December 22, 2023
Effects of nintedanib on symptoms in patients with progressive pulmonary fibrosisMarlies Wijsenbeek, Jeffrey J Swigris, Yoshikazu Inoue, et al.
The Lancet. Respiratory Medicine|December 10, 2016
The diagnosis of idiopathic pulmonary fibrosis: current and future approachesFernando J Martinez, Alison Chisholm, Harold R Collard, et al.
Arthritis and Rheumatism|August 6, 2005
Comparison of disease progression and mortality of connective tissue disease-related interstitial lung disease and idiopathic interstitial pneumoniaS V Kocheril, B E Appleton, E C Somers, et al.
Respiratory Medicine|February 3, 2016
Hypersensitivity pneumonitis and antigen identification--An alternate approachM L Millerick-May, M H Mulks, J Gerlach, et al.
Pageof 25